BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2577255)

  • 1. A Brief History of Glandular Therapy: More Than Just Thyroid.
    Isaacs LL
    Integr Med (Encinitas); 2023 May; 22(2):26-31. PubMed ID: 37363152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin Receptor Blocking Antibodies.
    Diana T; Olivo PD; Kahaly GJ
    Horm Metab Res; 2018 Dec; 50(12):853-862. PubMed ID: 30286485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic myxedema and blocking type antibodies to TSH receptor].
    Mitsuma T
    Nihon Rinsho; 1999 Aug; 57(8):1759-63. PubMed ID: 10483246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases.
    Gupta MK
    Clin Biochem; 1992 Jun; 25(3):193-9. PubMed ID: 1633635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema.
    Iida Y; Konishi J; Kasagi K; Misaki T; Arai K; Tokuda Y; Torizuka K
    J Clin Endocrinol Metab; 1987 Jan; 64(1):124-30. PubMed ID: 3023425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
    Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient neonatal hypothyroidism due to transplacental transfer of maternal immunoglobulins that inhibit TSH binding, TSH-induced cAMP increase and cell growth.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Lee M
    Endocrinol Jpn; 1988 Dec; 35(6):819-26. PubMed ID: 2907987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid growth-blocking antibodies in primary myxoedema.
    Drexhage HA; Bottazzo GF; Bitensky L; Chayen J; Doniach D
    Nature; 1981 Feb; 289(5798):594-6. PubMed ID: 7464924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of goitrous autoimmune thyroiditis with HLA-DR5.
    Farid NR; Sampson L; Moens H; Barnard JM
    Tissue Antigens; 1981 Mar; 17(3):265-8. PubMed ID: 6947505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.
    Bogner U; Schleusener H; Wall JR
    J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins.
    Matsuura N; Yamada Y; Nohara Y; Konishi J; Kasagi K; Endo K; Kojima H; Wataya K
    N Engl J Med; 1980 Sep; 303(13):738-41. PubMed ID: 6250031
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.